Jesse M. Hall

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern

M. Peeples, J. Yount, Shan-Lu Liu, 2023, Proceedings of the National Academy of Sciences of the United States of America.

The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming

Kaitlin A. Read, Kenneth J. Oestreich, R. Deora, 2024, Frontiers in immunology.